04.16.2019 Issue 447

   
Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

HealthEconomics.Com Seeks Input
for 2019 Salary Survey

Monday, April 15

HealthEconomics.Com is seeking stakeholder input on its 3rd Bi-Annual 2019 HEOR, RWE & Market Access Global Salary Survey.

AARP Targets Pharma in Stop Rx Greed Campaign

AMCP Nexus Issues Call for Poster Abstracts

New FDA Initiative Expands Testing of RWE

ICER Posts Draft Scoping Document for RA Treatments

Sanofi Unveils Subscription Program for Insulin

PBMs Point Fingers at Pharma for High Prices

Broadcasting, Advertising Groups Oppose Rule on Drug Prices in Ads


US Market Access Engagement Manager/Director

Senior Medical Writer

Senior Research Analyst (HEOR)

Director, Real World Value and Evidence, Oncology

Industry Spotlight


Conferences Webinars
Economic Evaluation for Oncology
    April 23, York, England

Future of OCM and Advanced Payment Models in Oncology
    April 25, Chicago, Illinois

WHCC19
    April 28-May 1, Washington, D.C.

15th Annual Specialty Pharmacy Summit
    April 29-May 2, Las Vegas, Nevada

New Drug Pricing Strategies for a Changing Global Market
    April 24

Beyond Drug Development: The Increasing Role of Real-World Data and Real-World Evidence in Medical Research
    April 25

Surmounting Barriers to Adopting Biosimilar Therapies: Strategies for Achieving Goals of the Biologics Price Competition and Innovation Act
    April 30


Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Review of Influence: The Institute for Clinical and Economic Review

Innovative Drugs: Mapping the Pricing and Reimbursement Landscape

Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs, Biologics

Blockchain: Transformational Change for Pharma?

2018 Specialty Drug Trends

The Global Use of Medicine in 2019 and Outlook to 2023

Breaking Through the Hype of Real-World Evidence

Time to Market: Accelerating Market Access

Orphan Drugs in the United States

Charting Real World Data and Evidence – Activity and Capabilities (2018)


 
Special Thanks to Our Partners:
             Truven    
              Evidera    HealthCore    University of FL
Xcenda    OM1    Parexel    Jefferson     Dymaxium
Precision Xtract    Pharmerit    eMax Health    Sciformix
Evidence Partners     ICON
Share this newsletter on social media:

Email Twitter Facebook LinkedIn